NAM
BMRN icon

NorthCrest Asset Manangement’s BioMarin Pharmaceuticals BMRN Stock Holding History

NorthCrest Asset Manangement’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$478K Sell
7,974
-2,752
-26% -$151K 0.01% 579
2026
Q1 		$595K Sell
10,726
-1,757
-14% -$102K 0.02% 428
2025
Q4 		$735K Buy
12,483
+564
+5% +$30.7K 0.02% 435
2025
Q3 		$652K Buy
11,919
+8,412
+240% +$481K 0.02% 423
2025
Q2 		$202K Sell
3,507
-1,378
-28% -$81.1K 0.01% 605
2025
Q1 		$345K Buy
+4,885
New +$329K 0.01% 487

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $711M AUM 27.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIA
Cascade Investment Advisors Oregon City, Oregon $183M AUM 29.64% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return